BRAINSTORM CELL THERAPEUTICS INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $5.5M | $11.4M | $2.5M |
| FY2018 | $6.2M | $11.2M | $942.0K |
| FY2019 | $18.8M | $6.5M | $536.0K |
| FY2020 | $15.8M | $51.3M | $37.8M |
| FY2021 | $9.9M | $29.3M | $18.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $5.5M | $11.4M | $2.5M |
| FY2018 | $6.2M | $11.2M | $942.0K |
| FY2019 | $18.8M | $6.5M | $536.0K |
| FY2020 | $15.8M | $51.3M | $37.8M |
| FY2021 | $9.9M | $29.3M | $18.9M |